McMaster advances the fight against antimicrobial resistance with new antibiotics, AI and funding
McMaster reports multiple AMR advances: discovery of new antibiotics (manikomycin, lariocidins, enterololin), an AI‑designed candidate (synthecin), antifungal adjuvant findings, national prescribing guidance and >$2M to advance enterololin toward trials.
Researchers at McMaster identified several promising antimicrobial candidates: manikomycin (a novel mechanism), lariocidins (a new antibiotic class), and enterololin, which received over $2M from the Weston Family Foundation to accelerate development. An AI model (SyntheMol‑RL) generated synthecin, shown effective in mouse wound models. The university also helped publish Canadian antibiotic prescribing guidance and research on antifungal adjuvants and phage‑derived vulnerabilities that could inform future therapies.
Read the original story · McMaster University — https://news.mcmaster.ca/world-amr-awareness-week-10-ways-mcmaster-is-fighting-back-against-drug-resistance/